[{"address1": "88 Sidney Street", "city": "Cambridge", "state": "MA", "zip": "02139", "country": "United States", "phone": "617 649 8600", "website": "https://www.agios.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product is also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatric patients; and AQVESME for the treatment of adult patients with non-transfusion dependent and transfusion-dependent alpha- or beta-thalassemia. In addition, it developed tebapivat, a PK activator for the treatment of lower-risk myelodysplastic syndrome and sickle cell disease; AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria (PKU); and AG-236, an siRNA in-licensed from Alnylam, targeting the transmembrane serine protease 6 (TMPRSS6) gene for the treatment of polycythemia vera. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Brian M. Goff M.B.A.", "age": 56, "title": "CEO & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1553274, "exercisedValue": 0, "unexercisedValue": 1463479}, {"maxAge": 1, "name": "Dr. Lewis clayton Cantley Ph.D.", "age": 76, "title": "Co-Founder", "yearBorn": 1949, "fiscalYear": 2024, "totalPay": 50000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tak Wah Mak D.Sc., FRSC, Ph.D.", "age": 79, "title": "Co-Founder", "yearBorn": 1946, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Craig B. Thompson M.D.", "age": 72, "title": "Co-Founder", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shin-San  Su Ph.D.", "age": 69, "title": "Co-Founder", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. T. J. Washburn", "age": 43, "title": "VP, Controller & Principal Accounting Officer", "yearBorn": 1982, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Morgan G. Sanford", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven  Vickers", "title": "Vice President of Sales", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Krishnan  Viswanadhan M.B.A., Pharm.D.", "age": 46, "title": "Chief Corporate Development & Strategy Officer", "yearBorn": 1979, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ellen  Lopresti", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 3, "compensationRisk": 4, "shareHolderRightsRisk": 7, "overallRisk": 4, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 28.07, "open": 28.715, "dayLow": 27.76, "dayHigh": 28.97, "regularMarketPreviousClose": 28.07, "regularMarketOpen": 28.715, "regularMarketDayLow": 27.76, "regularMarketDayHigh": 28.97, "payoutRatio": 0.0, "forwardPE": -5.231752, "volume": 614823, "regularMarketVolume": 614823, "averageVolume": 1710246, "averageVolume10days": 886890, "averageDailyVolume10Day": 886890, "bid": 27.86, "ask": 28.07, "bidSize": 1, "askSize": 1, "marketCap": 1638237056, "fiftyTwoWeekLow": 22.24, "fiftyTwoWeekHigh": 46.0, "allTimeHigh": 138.85, "allTimeLow": 15.77, "priceToSalesTrailing12Months": 30.322, "fiftyDayAverage": 27.364, "twoHundredDayAverage": 34.0864, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "profitMargins": 0.0, "floatShares": 52166784, "sharesOutstanding": 58592172, "sharesShort": 6728796, "sharesShortPriorMonth": 7089960, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.1154, "heldPercentInsiders": 0.0174, "heldPercentInstitutions": 1.0783, "shortRatio": 7.08, "shortPercentOfFloat": 0.1162, "impliedSharesOutstanding": 58592172, "bookValue": 22.037, "priceToBook": 1.2687751, "lastFiscalYearEnd": 1767139200, "nextFiscalYearEnd": 1798675200, "mostRecentQuarter": 1767139200, "netIncomeToCommon": -412780992, "trailingEps": -7.12, "forwardEps": -5.34429, "52WeekChange": -0.16483188, "SandP52WeekChange": 0.11471915, "quoteType": "EQUITY", "currentPrice": 27.96, "targetHighPrice": 65.0, "targetLowPrice": 25.0, "targetMeanPrice": 38.125, "targetMedianPrice": 36.5, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "ebitda": -466917344, "totalRevenue": 54028000, "debtToEquity": 3.466, "revenuePerShare": 0.932, "returnOnEquity": -0.2922, "grossProfits": 47683000, "revenueGrowth": 0.861, "grossMargins": 0.88255996, "ebitdaMargins": 0.0, "operatingMargins": -6.08895, "financialCurrency": "USD", "symbol": "AGIO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Agios Pharmaceuticals, Inc.", "longName": "Agios Pharmaceuticals, Inc.", "regularMarketChangePercent": -0.39188, "regularMarketPrice": 27.96, "corporateActions": [], "marketState": "CLOSED", "earningsTimestamp": 1770903000, "earningsTimestampStart": 1777555800, "earningsTimestampEnd": 1777555800, "earningsCallTimestampStart": 1770901200, "earningsCallTimestampEnd": 1770901200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -7.12, "epsForward": -5.34429, "epsCurrentYear": -6.50333, "priceEpsCurrentYear": -4.2993355, "fiftyDayAverageChange": 0.59599876, "fiftyDayAverageChangePercent": 0.021780396, "twoHundredDayAverageChange": -6.1264, "twoHundredDayAverageChangePercent": -0.1797315, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "postMarketTime": 1771030419, "regularMarketTime": 1771016402, "exchange": "NMS", "messageBoardId": "finmb_46539787", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1374672600000, "postMarketChangePercent": 0.1072986, "postMarketPrice": 27.99, "postMarketChange": 0.030000687, "regularMarketChange": -0.110001, "regularMarketDayRange": "27.76 - 28.97", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1710246, "fiftyTwoWeekLowChange": 5.7199993, "fiftyTwoWeekLowChangePercent": 0.25719422, "fiftyTwoWeekRange": "22.24 - 46.0", "fiftyTwoWeekHighChange": -18.04, "fiftyTwoWeekHighChangePercent": -0.39217395, "fiftyTwoWeekChangePercent": -16.483189, "displayName": "Agios Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-02-14"}]